Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVDTK.L Regulatory News (VDTK)

  • There is currently no data for VDTK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Sep 2020 07:00

RNS Number : 5369Y
Verditek PLC
10 September 2020
 

Verditek plc

Issue of Equity on Conversion of Convertible Loan Note and Settlement of Adviser Fees

 

Verditek plc ("Verditek" or "Company"), the international clean technology company that develops, manufactures and sells certified lightweight solar panels, announces that it has received a notice of conversion of£100,000 of convertible loan notes ("CLN's") at 10 pence per share. This, together with accrued interest, means 1,184,544 new ordinary shares are due to be issued. There remains a balance of issued CLN's of £70,000. In addition, the company has allotted 590,909 new ordinary shares in settlement of PR adviser fees.

Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will occur at 8.00 a.m. on 15 September 2020. The new ordinary shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after the admission of the new ordinary shares, and will otherwise be identical to and rank pari passu in all respects with the existing ordinary shares.

Following Admission of the 1,775,453 new ordinary shares, Verditek will have 297,422,443 ordinary shares in issue and admitted to trading on AIM. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

Enquiries:

Verditek plc

RH Lord David Willetts FRS (Non-Executive Chairman)

Rob Richards (Chief Executive Officer)

 

 

Tel: +44 (0)20 7129 1110enquiries@verditek.plc.uk

 

WH Ireland Limited (NOMAD and Broker)

 

 

Tel: +44 (0)20 7220 1666

Chris Hardie (Corporate Finance)

Matthew Chan

 

 

About Verditek plc

AIM listed Verditek plc is a holding company with three businesses operating within the clean technology sector. The Company is focused on commercializing our lightweight low-profile solar panel business. With manufacturing based in Lainate Italy, we have developed renewable power solutions for our customers that drive solar energy into applications previously impossible. The exceptional properties of our solar panels replace diesel fuel in business such as perishable goods transport, off-grid telecommunication towers, electric vehicle charging stations, residential and holiday home power solutions and solar roofing for light-weight industrial roofing. In addition to our current PV panels in production, we have partnered with an outstanding leader in graphene technology, Paragraf, and have created the worlds' first Graphene Integrated Photo Voltaic cell. We are working together to engineer the technology for commercialization.

 

Verditek provides compelling commercial solutions that make our customers business sustainable.

 

For more information please visit or contact the following: https://verditek.com/

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUPUGCBUPUGQB
Date   Source Headline
7th Sep 20223:19 pmRNSInterim Report for the Six Months to 30 June 2022
5th Aug 20225:10 pmRNSResult of AGM
8th Jul 20222:05 pmRNSSecond Price Monitoring Extn
8th Jul 20222:00 pmRNSPrice Monitoring Extension
8th Jul 20229:27 amRNSNotice of AGM
7th Jul 20221:04 pmRNSTR1: Notification of Major Holdings
7th Jul 202211:54 amRNSTR1: Notification of Major Holdings
30th Jun 20229:06 amRNSSecond Price Monitoring Extn
30th Jun 20229:00 amRNSPrice Monitoring Extension
30th Jun 20227:05 amRNSSubscription of Ordinary Shares to Raise £1.52m
30th Jun 20227:00 amRNSFinal Audited Results and Change of Address
27th Jun 202211:05 amRNSSecond Price Monitoring Extn
27th Jun 202211:00 amRNSPrice Monitoring Extension
27th Jun 20227:00 amRNSBradclad Group secures JV with Protan AB
21st Jun 20224:40 pmRNSSecond Price Monitoring Extn
21st Jun 20224:36 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSSale of Investment in ICSI
26th Jan 20227:00 amRNSParagraf & Verditek - Project Update
29th Oct 20217:00 amRNSCrowd for Angels (UK) Limited Bond and Warrant
20th Sep 20217:00 amRNSGrant of Share Options
13th Sep 20217:00 amRNSInnovate UK Grant Award
26th Aug 20214:41 pmRNSSecond Price Monitoring Extn
26th Aug 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20217:00 amRNSInterim Report for the six months to 30 June 2021
10th Aug 20217:00 amRNSCrowd for Angels (UK) Limited Bond
30th Jul 20217:00 amRNSResult of AGM
30th Jun 20217:00 amRNSFinal Audited Results
24th Jun 20217:00 amRNSFactory Update
1st Jun 20217:00 amRNSCrowd for Angels (UK) Limited Loan
7th Apr 20212:06 pmRNSSecond Price Monitoring Extn
7th Apr 20212:01 pmRNSPrice Monitoring Extension
6th Apr 20214:42 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSProduct Enhancement and Order Update
16th Mar 20214:41 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20212:06 pmRNSSecond Price Monitoring Extn
16th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20212:05 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
28th Jan 202111:05 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 202111:05 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 20218:11 amRNSYear-end Update
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.